Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Biotech, Inc.
Beth Israel Deaconess Medical Center
Brain Inflammation Collaborative
Northwestern University
Hospital Clinico Universitario de Santiago
Sahlgrenska University Hospital
Second Affiliated Hospital of Wenzhou Medical University
Assistance Publique Hopitaux De Marseille
M.D. Anderson Cancer Center
University of Pittsburgh
Radboud University Medical Center
ProgenaBiome
Odense University Hospital
AbbVie
Pfizer
Alimentiv Inc.
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Institut du Cancer de Montpellier - Val d'Aurelle
Janssen Scientific Affairs, LLC
VitaMed Research LLC
Universitaire Ziekenhuizen KU Leuven
Takeda
Sanguine Biosciences
Assistance Publique - Hôpitaux de Paris
Viome
Hospital Galdakao-Usansolo
University of Basel
The University of Texas Medical Branch, Galveston
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Queen Mary University of London
Alliance Foundation Trials, LLC.
Assistance Publique - Hôpitaux de Paris
OMNI Medical Services, LLC
Centre Hospitalier Universitaire de Nice
University Hospitals Cleveland Medical Center
Hoffmann-La Roche
Kantonsspital Winterthur KSW
Universitaire Ziekenhuizen KU Leuven
Hoffmann-La Roche
Hoffmann-La Roche
National Cancer Institute (NCI)
Hoffmann-La Roche
Takeda
Hikma Pharmaceuticals LLC
Charite University, Berlin, Germany
Charite University, Berlin, Germany
Stanford University
Istituto Clinico Humanitas
Mayo Clinic